Literature DB >> 17166230

Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains.

Viktoria Hancock1, Lionel Ferrières, Per Klemm.   

Abstract

Escherichia coli is the most common organism associated with asymptomatic bacteriuria (ABU) in humans. In contrast to uropathogenic E. coli (UPEC) that cause symptomatic urinary tract infection, very little is known about the mechanisms by which these strains colonize the urinary tract. Here, we have investigated the biofilm-forming capacity on abiotic surfaces of groups of ABU strains and UPEC strains in human urine. We found that there is a strong bias; ABU strains were significantly better biofilm formers than UPEC strains. Our data suggest that biofilm formation in urinary tract infectious E. coli seems to be associated with ABU strains and appears to be an important strategy used by these strains for persistence in this high-flow environment.

Entities:  

Mesh:

Year:  2006        PMID: 17166230     DOI: 10.1111/j.1574-6968.2006.00507.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  25 in total

1.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

Review 2.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

3.  Blocking of bacterial biofilm formation by a fish protein coating.

Authors:  Rebecca Munk Vejborg; Per Klemm
Journal:  Appl Environ Microbiol       Date:  2008-04-18       Impact factor: 4.792

4.  A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972.

Authors:  Rebecca Munk Vejborg; Carsten Friis; Viktoria Hancock; Mark A Schembri; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-03-31       Impact factor: 3.291

5.  Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine.

Authors:  Viktoria Hancock; Per Klemm
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

6.  Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for fur.

Authors:  Viktoria Hancock; Malin Dahl; Per Klemm
Journal:  Appl Environ Microbiol       Date:  2010-04-23       Impact factor: 4.792

7.  Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine.

Authors:  Rebecca M Vejborg; Mari R de Evgrafov; Minh Duy Phan; Makrina Totsika; Mark A Schembri; Viktoria Hancock
Journal:  Infect Immun       Date:  2012-07-02       Impact factor: 3.441

8.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.

Authors:  Evan M Hetrick; Jae Ho Shin; Heather S Paul; Mark H Schoenfisch
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

Review 9.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

10.  Defining a Molecular Signature for Uropathogenic versus Urocolonizing Escherichia coli: The Status of the Field and New Clinical Opportunities.

Authors:  Allison R Eberly; Connor J Beebout; Ching Man Carmen Tong; Gerald T Van Horn; Hamilton D Green; Madison J Fitzgerald; Shuvro De; Emily K Apple; Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean; Douglass B Clayton; Charles W Stratton; Jonathan E Schmitz; Maria Hadjifrangiskou
Journal:  J Mol Biol       Date:  2019-11-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.